*By Michael Teich*
Ethical issues could be the Achilles heel for Juul, the $15 billion company behind the vaping devices infiltrating college and high school campuses.
"The valuation is justified on the math," said Dan Primack, Business Editor at Axios. The real question, though, is, "Does it want to stop kids from getting these?"
The sleek and colorful design of the company's e-cigarettes, paired with appealing flavors such as mango and cool mint, has helped Juul emerge as a leader in the market with a 68 percent share, according to Wells Fargo. The company projects $940 million in revenue this year, but Primack said he's told that "they are blowing through those numbers." Those numbers helped Juul raise a fresh $1.2 billion in new funding last week.
But strong sales growth may not be enough to entice more traditional Silicon Valley investors to overlook the moral complexities of Juul's business, Primack said.
While the device was created as an alternative to cigarettes, he pointed out the product is falling into the hands of first-time smokers and serves as a "gateway smoke."
For the full segment, [click here.](https://cheddar.com/videos/the-ethical-issues-that-may-plague-juuls-future)
Joe Spector, founder of Dutch and Hims & Hers co-founder, joins us to discuss how telehealth is transforming pet care—and what’s next for modern vet medicine.
Exclusive: Behr’s Andy Lopez reveals how ChatHUE, a bold collaboration with Google, is using AI to transform how we explore, choose, and connect with color.
Brian Vendig, President & CIO of MJP Wealth Advisors, joins to break down Q2 bank earnings and what they signal for markets, investors, and the economy ahead.
Are Gen Z and Millennials done with alcohol? Bacardi's Tony Latham breaks down trends, new preferences, and insights from the 2025 Cocktail Trends Report.
Comscore’s Paul Dergarabedian breaks down the battle of summer blockbusters, from Superman to Jurassic World and Fantastic Four and what it means for studios.
VENU CEO JW Roth breaks ground on a 20,000-seat, state-of-the-art amphitheater in Texas—part of a $300M public-private expansion to redefine live music.
Despite healthcare spending cuts, medtech stocks like Edwards Life Sciences, Stryker, and Boston Scientific are rising, especially those serving older pati
Joby CPO Eric Allison discusses the UAE’s historic EVTOL take off, marking Dubai as the launchpad for global air taxi adoption and Joby’s commercial readiness.
